LZTR1 and cancer: According to the results, LZTR1 might be a potential target or cancer immune therapy in READ, ACC, LGG, OV, BRCA, PCPG, LUSC, LUAD, PRAD, LIHC, BLCA, DLBC READ, and COAD.